Top compounds associated with response to MAP2


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 4e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 4e-08
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.21 6e-08
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 5e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.18 6e-06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 8e-06
mRNA AUY922 GDSC1000 pan-cancer AAC -0.18 1e-05
Download CSV